ATLL cases with PD-L1 expression in tumor cells had inferior overall survival compared with ATLL cases with null PD-L1 expression or stromal PD-L1 expression with the median survival time of 7.5, 10.2 and 18.6 months, respectively [216]. This evidence concerns the gene CD274 and neoplasm.